Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 1999 Feb;75(1):18–20. doi: 10.1136/sti.75.1.18

Changing patterns of HIV related ocular disease

S Rauz, P I Murray
PMCID: PMC1758167  PMID: 10448336

Abstract

Cytomegalovirus (CMV) retinitis is the commonest ocular complication of AIDS and the prevention of recurrence has been dependent on lifelong maintenance treatment. Recently there has been a dramatic downturn in the number of new cases of CMV retinitis, which has been attributed to the introduction of highly active antiretroviral therapy (HAART) and subsequent improved survival. Whereas paucity of inflammation has been considered to be the hallmark of the ophthalmic manifestations of AIDS, with immune recovery, a new pattern of ophthalmic AIDS has emerged. This is characterised by a heightened inflammatory response and more frequent complications associated with this response--for example, vitritis, cystoid macular oedema. In spite of this, regression of CMV retinitis has been reported, as well as absence of reactivation or progression after withdrawal of anti-CMV maintenance treatment. How long this situation will continue is not known and we remain cautious about the future of CMV retinitis and other opportunistic ocular infections. 




Full Text

The Full Text of this article is available as a PDF (74.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aboulker J. P., Swart A. M. Preliminary analysis of the Concorde trial. Concorde Coordinating Committee. Lancet. 1993 Apr 3;341(8849):889–890. doi: 10.1016/0140-6736(93)93096-j. [DOI] [PubMed] [Google Scholar]
  2. Bartlett J. A., Benoit S. L., Johnson V. A., Quinn J. B., Sepulveda G. E., Ehmann W. C., Tsoukas C., Fallon M. A., Self P. L., Rubin M. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party. Ann Intern Med. 1996 Aug 1;125(3):161–172. doi: 10.7326/0003-4819-125-3-199608010-00001. [DOI] [PubMed] [Google Scholar]
  3. Burd E. M., Pulido J. S., Puro D. G., O'Brien W. J. Maintenance of replicative intermediates in ganciclovir-treated human cytomegalovirus-infected retinal glia. Arch Ophthalmol. 1996 Jul;114(7):856–861. doi: 10.1001/archopht.1996.01100140070011. [DOI] [PubMed] [Google Scholar]
  4. Collier A. C., Coombs R. W., Schoenfeld D. A., Bassett R. L., Timpone J., Baruch A., Jones M., Facey K., Whitacre C., McAuliffe V. J. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med. 1996 Apr 18;334(16):1011–1017. doi: 10.1056/NEJM199604183341602. [DOI] [PubMed] [Google Scholar]
  5. Connors M., Kovacs J. A., Krevat S., Gea-Banacloche J. C., Sneller M. C., Flanigan M., Metcalf J. A., Walker R. E., Falloon J., Baseler M. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med. 1997 May;3(5):533–540. doi: 10.1038/nm0597-533. [DOI] [PubMed] [Google Scholar]
  6. Coombs R. W., Welles S. L., Hooper C., Reichelderfer P. S., D'Aquila R. T., Japour A. J., Johnson V. A., Kuritzkes D. R., Richman D. D., Kwok S. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups. J Infect Dis. 1996 Oct;174(4):704–712. doi: 10.1093/infdis/174.4.704. [DOI] [PubMed] [Google Scholar]
  7. Davis J. L., Taskintuna I., Freeman W. R., Weinberg D. V., Feuer W. J., Leonard R. E. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol. 1997 Jun;115(6):733–737. doi: 10.1001/archopht.1997.01100150735008. [DOI] [PubMed] [Google Scholar]
  8. Drew W. L., Ives D., Lalezari J. P., Crumpacker C., Follansbee S. E., Spector S. A., Benson C. A., Friedberg D. N., Hubbard L., Stempien M. J. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. N Engl J Med. 1995 Sep 7;333(10):615–620. doi: 10.1056/NEJM199509073331002. [DOI] [PubMed] [Google Scholar]
  9. Drew W. L., Miner R. C., Busch D. F., Follansbee S. E., Gullett J., Mehalko S. G., Gordon S. M., Owen W. F., Jr, Matthews T. R., Buhles W. C. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis. 1991 Apr;163(4):716–719. doi: 10.1093/infdis/163.4.716. [DOI] [PubMed] [Google Scholar]
  10. Dunn J. P., MacCumber M. W., Forman M. S., Charache P., Apuzzo L., Jabs D. A. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol. 1995 May;119(5):587–596. doi: 10.1016/s0002-9394(14)70217-x. [DOI] [PubMed] [Google Scholar]
  11. Farrell P. L., Heinemann M. H., Roberts C. W., Polsky B., Gold J. W., Mamelok A. Response of human immunodeficiency virus-associated uveitis to zidovudine. Am J Ophthalmol. 1988 Jul 15;106(1):7–10. doi: 10.1016/s0002-9394(14)76379-2. [DOI] [PubMed] [Google Scholar]
  12. Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. doi: 10.1056/NEJM198707233170401. [DOI] [PubMed] [Google Scholar]
  13. Gallant J. E., Moore R. D., Richman D. D., Keruly J., Chaisson R. E. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis. 1992 Dec;166(6):1223–1227. doi: 10.1093/infdis/166.6.1223. [DOI] [PubMed] [Google Scholar]
  14. Gottlieb M. S., Schroff R., Schanker H. M., Weisman J. D., Fan P. T., Wolf R. A., Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981 Dec 10;305(24):1425–1431. doi: 10.1056/NEJM198112103052401. [DOI] [PubMed] [Google Scholar]
  15. Gross J. G., Bozzette S. A., Mathews W. C., Spector S. A., Abramson I. S., McCutchan J. A., Mendez T., Munguia D., Freeman W. R. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1990 May;97(5):681–686. doi: 10.1016/s0161-6420(90)32552-6. [DOI] [PubMed] [Google Scholar]
  16. Hammer S. M., Squires K. E., Hughes M. D., Grimes J. M., Demeter L. M., Currier J. S., Eron J. J., Jr, Feinberg J. E., Balfour H. H., Jr, Deyton L. R. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997 Sep 11;337(11):725–733. doi: 10.1056/NEJM199709113371101. [DOI] [PubMed] [Google Scholar]
  17. Holland G. N. Pieces of a puzzle: Toward a better understanding of intraocular inflammation associated with human immunodeficiency virus disease. Am J Ophthalmol. 1998 Mar;125(3):383–385. doi: 10.1016/s0002-9394(99)80150-0. [DOI] [PubMed] [Google Scholar]
  18. Hoover D. R., Peng Y., Saah A., Semba R., Detels R. R., Rinaldo C. R., Jr, Phair J. P. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol. 1996 Jul;114(7):821–827. doi: 10.1001/archopht.1996.01100140035004. [DOI] [PubMed] [Google Scholar]
  19. Jabs D. A., Bartlett J. G. AIDS and ophthalmology: a period of transition. Am J Ophthalmol. 1997 Aug;124(2):227–233. doi: 10.1016/s0002-9394(14)70789-5. [DOI] [PubMed] [Google Scholar]
  20. Jabs D. A., Green W. R., Fox R., Polk B. F., Bartlett J. G. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989 Jul;96(7):1092–1099. doi: 10.1016/s0161-6420(89)32794-1. [DOI] [PubMed] [Google Scholar]
  21. Jacobs D. S., Piliero P. J., Kuperwaser M. G., Smith J. A., Harris S. D., Flanigan T. P., Goldberg J. H., Ives D. V. Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection. Am J Ophthalmol. 1994 Dec 15;118(6):716–722. doi: 10.1016/s0002-9394(14)72550-4. [DOI] [PubMed] [Google Scholar]
  22. Jacobson M. A., Zegans M., Pavan P. R., O'Donnell J. J., Sattler F., Rao N., Owens S., Pollard R. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 1997 May 17;349(9063):1443–1445. doi: 10.1016/S0140-6736(96)11431-8. [DOI] [PubMed] [Google Scholar]
  23. Karavellas M. P., Lowder C. Y., Macdonald C., Avila C. P., Jr, Freeman W. R. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol. 1998 Feb;116(2):169–175. doi: 10.1001/archopht.116.2.169. [DOI] [PubMed] [Google Scholar]
  24. Kuppermann B. D., Petty J. G., Richman D. D., Mathews W. C., Fullerton S. C., Rickman L. S., Freeman W. R. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993 May 15;115(5):575–582. doi: 10.1016/s0002-9394(14)71453-9. [DOI] [PubMed] [Google Scholar]
  25. Levinson R. D., Vann R., Davis J. L., Friedberg D. N., Tufail A., Terry B. T., Lindley J. I., Holland G. N. Chronic multifocal retinal infiltrates in patients infected with human immunodeficiency virus. Am J Ophthalmol. 1998 Mar;125(3):312–324. doi: 10.1016/s0002-9394(99)80137-8. [DOI] [PubMed] [Google Scholar]
  26. Macdonald J. C., Torriani F. J., Morse L. S., Karavellas M. P., Reed J. B., Freeman W. R. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis. 1998 May;177(5):1182–1187. doi: 10.1086/515281. [DOI] [PubMed] [Google Scholar]
  27. Maguire A. M., Nichols C. W., Crooks G. W. Visual loss in cytomegalovirus retinitis caused by cystoid macular edema in patients without the acquired immune deficiency syndrome. Ophthalmology. 1996 Apr;103(4):601–605. doi: 10.1016/s0161-6420(96)30646-5. [DOI] [PubMed] [Google Scholar]
  28. Martin D. F., Parks D. J., Mellow S. D., Ferris F. L., Walton R. C., Remaley N. A., Chew E. Y., Ashton P., Davis M. D., Nussenblatt R. B. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol. 1994 Dec;112(12):1531–1539. doi: 10.1001/archopht.1994.01090240037023. [DOI] [PubMed] [Google Scholar]
  29. Nussenblatt R. B., Lane H. C. Human immunodeficiency virus disease: changing patterns of intraocular inflammation. Am J Ophthalmol. 1998 Mar;125(3):374–382. doi: 10.1016/s0002-9394(99)80149-4. [DOI] [PubMed] [Google Scholar]
  30. Palella F. J., Jr, Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–860. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
  31. Palestine A. G., Frishberg B. Macular edema in acquired immunodeficiency syndrome-related microvasculopathy. Am J Ophthalmol. 1991 Jun 15;111(6):770–771. doi: 10.1016/s0002-9394(14)76788-1. [DOI] [PubMed] [Google Scholar]
  32. Palestine A. G., Polis M. A., De Smet M. D., Baird B. F., Falloon J., Kovacs J. A., Davey R. T., Zurlo J. J., Zunich K. M., Davis M. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1991 Nov 1;115(9):665–673. doi: 10.7326/0003-4819-115-9-665. [DOI] [PubMed] [Google Scholar]
  33. Pepose J. S., Newman C., Bach M. C., Quinn T. C., Ambinder R. F., Holland G. N., Hodstrom P. S., Frey H. M., Foos R. Y. Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir. Ophthalmology. 1987 Apr;94(4):414–424. doi: 10.1016/s0161-6420(87)33455-4. [DOI] [PubMed] [Google Scholar]
  34. Pertel P., Hirschtick R., Phair J., Chmiel J., Poggensee L., Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 1992;5(11):1069–1074. [PubMed] [Google Scholar]
  35. Reed J. B., Schwab I. R., Gordon J., Morse L. S. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol. 1997 Aug;124(2):199–205. doi: 10.1016/s0002-9394(14)70784-6. [DOI] [PubMed] [Google Scholar]
  36. Rosberger D. F., Heinemann M. H., Friedberg D. N., Holland G. N. Uveitis associated with human immunodeficiency virus infection. Am J Ophthalmol. 1998 Mar;125(3):301–305. doi: 10.1016/s0002-9394(99)80135-4. [DOI] [PubMed] [Google Scholar]
  37. Sepkowitz K. A. Effect of HAART on natural history of AIDS-related opportunistic disorders. Lancet. 1998 Jan 24;351(9098):228–230. doi: 10.1016/S0140-6736(05)78279-9. [DOI] [PubMed] [Google Scholar]
  38. Smith I. L., Taskintuna I., Rahhal F. M., Powell H. C., Ai E., Mueller A. J., Spector S. A., Freeman W. R. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol. 1998 Feb;116(2):178–185. doi: 10.1001/archopht.116.2.178. [DOI] [PubMed] [Google Scholar]
  39. Spector S. A., Weingeist T., Pollard R. B., Dieterich D. T., Samo T., Benson C. A., Busch D. F., Freeman W. R., Montague P., Kaplan H. J. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis. 1993 Sep;168(3):557–563. doi: 10.1093/infdis/168.3.557. [DOI] [PubMed] [Google Scholar]
  40. Voelker R. Physicians face new contradictions in HIV care. JAMA. 1997 May 21;277(19):1504–1505. [PubMed] [Google Scholar]
  41. Vrabec T. R., Baldassano V. F., Whitcup S. M. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology. 1998 Jul;105(7):1259–1264. doi: 10.1016/S0161-6420(98)97031-2. [DOI] [PubMed] [Google Scholar]
  42. Walsh J. C., Jones C. D., Barnes E. A., Gazzard B. G., Mitchell S. M. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors. AIDS. 1998 Apr 16;12(6):613–618. doi: 10.1097/00002030-199806000-00010. [DOI] [PubMed] [Google Scholar]
  43. Weinberg D. V., Moorthy R. S. Cystoid macular edema due to cytomegalovirus retinitis in a patient with acquired immune deficiency syndrome. Retina. 1996;16(4):343–344. doi: 10.1097/00006982-199616040-00013. [DOI] [PubMed] [Google Scholar]
  44. Whitcup S. M., Fortin E., Nussenblatt R. B., Polis M. A., Muccioli C., Belfort R., Jr Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. JAMA. 1997 May 21;277(19):1519–1520. [PubMed] [Google Scholar]
  45. Zegans M. E., Walton R. C., Holland G. N., O'Donnell J. J., Jacobson M. A., Margolis T. P. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 1998 Mar;125(3):292–300. doi: 10.1016/s0002-9394(99)80134-2. [DOI] [PubMed] [Google Scholar]
  46. van den Horn G. J., Meenken C., Danner S. A., Reiss P., de Smet M. D. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients. Br J Ophthalmol. 1998 Sep;82(9):988–990. doi: 10.1136/bjo.82.9.988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES